In many resource-poor countries, HIV-infected patients receive a standardized antiretroviral cocktail. In these settings, population-level surveillance of drug resistance is needed to characterize the prevalence of resistance mutations and to enable antiretroviral therapy programs to select the optimal regimen for their local population. The surveillance strategy currently recommended by the World Health Organization is prohibitively expensive in some settings and may not provide a sufficiently precise rendering of the emergence of drug resistance. By using a novel assay on pooled sera samples, we decrease surveillance costs while simultaneously increasing the accuracy of drug resistance prevalence estimates for an important mutation that impacts first-line antiretroviral therapy. We present a Bayesian model for pooled-testing data that garners more information from each resistance assay conducted, compared with individual testing. We expand on previous pooling methods to account for uncertainty about the population distribution of within-subject resistance levels. In addition, our model accounts for measurement error of the resistance assay, and this added uncertainty naturally propagates through the Bayesian model to our inference on the prevalence parameter. We conduct a simulation study that informs our pool size recommendations and that shows that this model renders the prevalence parameter identifiable in instances when an existing non-model-based estimator fails.
et al. 7 found the prevalence of transmitted drug resistance to be less than 5% in Chad. Vardavas and Blower 8 argue that the prevalences in other African countries are likely to fall below this threshold as well, concluding that 'although the BSLQAS method using a threshold value of 5% requires a small sample size and is relatively inexpensive it may actually not be cost-effective at the early stages of the treatment program.' In settings where prevalence is still very low, a low-cost sentinel surveillance system is needed to provide a higher-resolution picture of the emergence of primary drug resistance. Although Aghokeng et al. 7 found the prevalence of transmitted drug resistance to be greater than 5% in Cameroon, they still focus on the challenges presented by the WHO methodology, including cost and workload in particular.
The aim of this article is to specify a novel statistical method for analyzing results from a highly sensitive laboratory assay, 9 to allow detection of transmitted resistance at lower prevalence values than the WHO method and at a lower cost. We pursue prevalence estimation rather than classification, allowing us to provide the earliest possible warning of emerging primary drug resistance under new public-sector treatment programs, in settings where the population prevalence of resistant virus is still likely to be less than 5%.
The idea underlying our method is to cut costs by pooling blood samples from multiple individuals and performing a single allele-specific polymerase chain reaction (ASPCR) assay on the pool. Dorfman 10 first introduced pooled methods with the goal of 'detection of defective members of large populations'. Pooled detection algorithms have since been tailored for HIV research, optimizing screening for acute infections 11, 12 and, more recently, for virologic failure. 13, 14 Rather than individual detection though, our goal is prevalence estimation, building on the work of Tu et al. 15 Their method was adapted in Wein and Zenios 16 and in Zenios and Wein 17 to allow inference based on a continuous assay result.
In modeling drug resistance, an important challenge is that within an infected individual, HIV exists as a viral quasispecies, a group of genetically diverse strains. For this reason, an individual with drug resistance also harbors some non-zero proportion of non-resistant virus. A limitation of previous work [17] [18] [19] is the requirement that the population distribution of these within-subject resistance levels be known. Our model relaxes this assumption, using the Bayesian framework to account explicitly for our uncertainty about the parameters of this distribution.
Another challenge that arises in the pooled analysis of drug resistance data is that combining samples from subjects with differing viral loads may lead some resistance profiles to be under-or over-represented in the pooled sample. In order to avoid a situation where a sample with a high viral load of wild-type HIV mitigates the detection of a low viral load sample containing a drug resistance mutation, the pooling protocol must have equal input from each sample into the pool. Equal amounts of PCR amplicon as measured by spectrophotometry will be used in the pools, allowing us to make the assumption that each subject contributes an equal number of viral particles to the pool. However, the accuracy with which this step can be taken -as well as the accuracy's impact on our proposed method -remain to be studied.
Yet another difficulty that arises in drug resistance surveillance is the systematic, high-magnitude measurement error of the ASPCR assay. As Rowley et al. 9 show, a sample containing only 2% resistant virus may appear to have as much as 11% resistant virus, whereas a sample containing 10% resistant virus may appear to have as much as 33%, depending on non-drug-resistanceconferring polymorphisms in the primer binding site. Our model accounts for both the bias and for the added uncertainty due to measurement error.
In order to reduce the complexity of this analysis and to make 'drug resistance prevalence' a welldefined parameter, we make an important simplifying assumption and focus on the prevalence of a single point mutation, the nucleotide substitution at position 103 of reverse transcriptase that converts a lysine (ntAAA) to arginine (ntAAC), commonly known as a 'K103N mutation'. We choose to focus on the K103N mutation for a number of reasons. Firstly, K103N confers resistance to NVP and EFV, two important first-line drugs. Secondly, K103N is commonly occurring and can persist for years in the absence ofART drug pressure in individuals with transmitted resistance. 20 Lastly, Rowley et al. 9 use the K103N mutation as an example in their investigation of the measurement error associated with the ASPCR assay, and we thus have data with which to calibrate our measurement error model. Throughout, when we refer to 'drug-resistance', we mean the presence of the AAC mutation at location 103. 'Drug resistance prevalence', by extension, will be the population proportion of individuals with one or more copies of this K103N mutation. A practical advantage of focusing on K103N is that it allows us to use ASPCR, an assay that only provides information about a single allele and is thus less expensive than consensus sequencing. We discuss the relaxation of this simplifying assumption in section 5.
In section 2 we provide the statistical details of our proposed method. We then provide an indepth analysis of the likelihood in section 3, investigating the tradeoffs entailed in choosing a pool size and the problems that may arise if pools are too large. Lastly, in section 4, we present a simulation study comparing the results generated from our novel method to those obtained from an existing non-model-based estimation method.
A Bayesian model for pooled data
In this section, we present a Bayesian model that uses pooled-testing data to estimate the population-level prevalence of drug resistance and its uncertainty.
Let Y i denote the proportion of resistant virus in the ith pool member's plasma, with Y i ¼ 0 if subject i is not resistant. For subjects who are resistant, we assume that P(Y W Y > 0) is an unknown distribution with mean . We denote this distribution P y þ; we will describe its functional form in section 2.1.
Let p denote the population proportion of individuals with drug-resistant virus, our parameter of interest:
p ¼ PðY 4 0Þ: Then Y's distribution is a mixture of P y þ and a point mass at zero ( Figure 1 ):
Now consider pooling n independent samples of HIV-infected sera. Note that -since the samples have been standardized by viral load -Z is simply the average of the pool members' resistance levels:
The number of resistant individuals in the pool, k, is binomially distributed:
Ify i 4 0g $ Binomðn, pÞ:
The likelihood, P(z W k), is 1/n times a k-fold convolution of random variables with unknown distribution P y þ. The quintessential statistical challenge of pooled analyses is that the number of resistant pool members (k) is not observable, potentially impeding inference on p, our parameter of interest.
In the simplest case of pooled analysis, we would have (a) perfect knowledge of P y þ, and (b) an assay that measures resistance with perfect accuracy. In this case,
implies that an unbiased estimator of p is given byp ¼ z=. The focus of this study is to relax these two restrictions, allowing for uncertainty about P y þ and for measurement error. We allow for uncertainty about P y þ through its prior, as we describe in section 2.1, and we introduce a Bayesian measurement error model in section 2.2 in which the z's are no longer measured with perfect accuracy and thus become latent variables in our analysis. Although previous work in this area has accounted for measurement error, [15] [16] [17] [18] knowledge of Y's distribution has always been assumed. 17, 18 2.1 Accounting for uncertainty about the distribution of resistance levels
In order to account for uncertainty about P y þ, we embed the likelihood described above in a Bayesian model. An advantage of the Bayesian approach is that it provides a natural framework for allowing this uncertainty to propagate through the model to inference on p, our parameter of interest.
Importantly, note that in the absence of prior information about P y þ, p may not be identifiable. Consider, for example, an observed resistance level of z ¼ 0.2 in a pool of n ¼ 5 samples. This could represent 5 samples each with a resistance level of y ¼ 0.2, which would imply that p was large. However, z could equally well represent one completely resistant sample (y ¼ 1) and four nonresistant (y ¼ 0) samples, which would imply that p was small (Figure 2) .
We return to this identifiability issue in section 3. In this toy example, the only way to disentangle these possibilities would be to use prior information about P y þ. Since knowledge of P y þ is critical and will not always be available from the data, an informative prior for {Y W Y > 0} is needed. We therefore choose the shape of P y þ using prior knowledge of HIV viral dynamics.
It has been shown that approximately 78% of HIV transmission occurs as a result of infection with a single viral lineage from which all subsequent virus stems. 21 Primary resistance, then, often occurs as the result of infection with a single resistant viral lineage. We can thus infer that in the very early stages of infection with transmitted resistance, an individual's entire viral population will be resistant.
Since our goal is to estimate the prevalence of primary resistance among recently infected, treatment-naı¨ve individuals, this fact has important implications for P y þ, the distribution of resistance levels among those individuals with primary resistance. In particular, we propose to restrict the family of priors for {Y W Y > 0} to a continuum of truncated normal distributions that are all increasing in density from 0% to 100% resistance:
As shown in Figure 3 , this choice for P y þ reflects the virology of HIV transmission because most individuals enter into this population with 100% resistance and because the population is limited to those who were infected recently (i.e. their virus has not yet had time to revert to wild type 20 ). This constraint on the prior space helps to solve the identifiability problem depicted in Figure 2 . In particular, the large-p-low-scenario shown in the top row would be unlikely since the family of N (1, 2 ) I{0 y 1} distributions has values of in the 0.5-1.0 range. We note that in some cases the data may also provide information about ; however, as we show in section 3, this information will be lost if pool sizes are too large. Measurement error also confounds data-driven inference on (or equivalently, after a simple reparameterization, on ¼ 1 À ð0ÞÀð1=Þ Èð1=ÞÀÈð0Þ ). We put non-informative flat hyperpriors 22 on p and on .
Accounting for measurement error
An important generalization allows for measurement error of Z. It is known that standard genotypic assays have a lower bound of detection and that the ASPCR may yield biased results. 9 Thus, rather than observing Z itself, we observe W ¼ f(Z). We need to investigate the properties of f(Á) in order to calibrate this relationship and make valid inference on p.
We have gathered calibration data to describe the measurement error that occurs when using ASPCR to quantify levels of the K103N mutation in pooled samples. Samples with known true proportions of resistant virus (0%, 1%, 2.5%, 5%, 7.5%, 10%, and 20%) were assayed via ASPCR in order to obtain estimates of these true values. In this experiment, the K103N mutation was identified against a background of six non-resistant strains. We note, however, that the number and genotype of the pool's non-resistant background members is not expected to impact measurement error. In Figure 4 , we display the results, superimposing the following model
This model was chosen empirically as it appears to fit the data well. In other settings, alternative models may be preferred. Under measurement error, W becomes the observable data, Z becomes a latent variable, and equation 1 becomes the likelihood. . Calibration data illustrate the degree of ASPCR measurement error. We compare the logit of the observed resistance level (w) using allele-specific polymerase chain reaction (ASPCR) to the true resistance level in a sample (z). In blue, we show the distribution of points with z ¼ 0 (a 0 ¼ À7.7, v 0 ¼ 0.6); in green we show the linear association between z and logit w for those pools with
The R 2 of this measurement error model is 87%. The red line depicts a cutoff that we discuss in section 4.2. Figure 3 . Restricting the family of priors for {YW Y > 0} to a continuum of truncated normal distributions that all increase in density from 0% to 100% resistance yields a range of virologically reasonable priors.
Fitting the full model
Recall that Z's distribution is 1/n times a k-fold convolution of truncated normal random variables with distribution P yþ ¼ N (1, 2 ) I{0 y 1}. Note that and k thus fully determine the prior for Z, as shown in Figure 5 .
We let ¼ {a 0 , a 1 , v 0 , v 1 , b} denote the set of measurement error parameters. A complication that arises in implementing the measurement error model is that only the calibration data, and not the observed w's from the surveillance study, contain information about . Best 23 has shown that putting both types of data into a common model may lead to undesirable feedback from the w's to inference on . We thus wish to implement a model in which 's posterior distribution is informed by the calibration data alone.
An ad hoc option would be to obtain point estimates of the measurement error parameters using the calibration data, and then to treat these parameter estimates as known constants in subsequent analysis. However, this method ignores uncertainty about and may thus yield overly precise estimates of p.
An appealing alternative accounts for this uncertainty using a single probability model for the complete dataset, 'cutting feedback' 24, 25 from the observed w's to . This approach artificially drops the terms involving w's from the conditional distribution of the parameters. Although the resulting model is not a full probability model, Best 23 shows that the resulting inference may nonetheless be preferred. We adopt this strategy in fitting our model.
In order to fit the full model depicted in Figure 5 , allowing for measurement error, but cutting feedback from the simulated w's to the parameters of the measurement error model, we use two separate Markov chain Monte Carlo (MCMCs), as we describe in the Appendix. Rather than integrating k out to express Z's distribution as a function of p, we include both z and k as auxiliary variables that simplify the MCMC. We implement an adaptive Metropolis algorithm that yields good mixing. 
An analysis of the likelihood with implications for choosing a pool size
In this section, we describe the likelihood surface under two sets of 'true' parameter values given various pooled and non-pooled designs, in the absence of measurement error. (Note that since measurement error is not being considered in this section, the term 'likelihood' refers to P(z) rather than P(w) throughout.) We show that pooling can yield more efficient estimates of our parameter of interest, p. We also investigate the non-identifiability issue introduced in section 2.1. These results provide insight into the tradeoffs entailed in choosing a pool size and the problems that may arise if pools are too big.
In choosing the true parameter values, we are mindful of the context of HIV drug resistance surveillance in Africa. We set p ¼ 0.05 because we intend our approach to serve as a sentinel surveillance method, detecting low levels of drug resistance in new African ART programs, as described in the 'Introduction' section. We set , the mean of the truncated normal, equal to 0.9 since we expect to be near 1 in our population of recently infected individuals with primary resistance, as described in section 2.1. These data-generating truths are shown as green dots in Figure 6 . As an aside, recall that large corresponds to small -we parameterize in terms of here since it has a more intuitive interpretation.
For each candidate design, rather than simulating datasets given these parameter values, we deterministically set the proportion of resistant individuals equal to p, and we draw values of y evenly from the quantiles of the truncated normal distribution corresponding to ¼ 0.9. In this way, by using the data that are most likely given the 'true' parameter values, we prevent sampling variability from clouding our assessment. This allows optimal comparison of likelihood surfaces across designs. We note, however, that because sampling variability is removed and because measurement error is ignored, this analysis may make estimation of p appear deceptively clearcut. We reintroduce these two complications in the next section.
As depicted in Figure 6 , we pool according to 16 candidate designs, creating N ¼ 10, 50, 100, or 200 pools of size n ¼ 1, 10, 20, or 50. For each of these 16 simulated datasets, we calculate the likelihood on a grid of values such that the x-axis in Figure 6 shows values of p and the y-axis shows values of . For each design, the maximum likelihood value ðp,Þ is shown as a blue dot.
Estimation of p and is successful: we do not observe any systematic bias, and all confidence intervals (calculated using an asymptotic variance approximation from Tu et al. 15 ) cover their respective true values. The only exception is the {n ¼ 1, N ¼ 10} case in which we observe zero resistant individuals and are thus wholly unable to identify .
For any number N of tests performed, precision increases with the pool size n. These results suggest that we can reduce the cost of surveillance by pooling, and that for a true p of 0.05 -at least in the absence of measurement error -higher degrees of pooling are not detrimental.
Recall from section 2.1, however, that in certain instances, pooling may yield p non-identifiable. We now give an example of this potential lack of identifiability and describe the sources of information that our model uses to solve this problem. We repeat the analysis depicted in Figure 6 , increasing the true value of p to 0.1 and decreasing the true value of to 0.75. The results are shown in Figure 7 .
Note that as pool size increases, a ridge develops in the likelihood corresponding to E[z] ¼ p. For example, consider the N ¼ 50 column: we obtain a precise estimate of p with pool sizes of n ¼ 10 and n ¼ 20, but for n ¼ 50, a ridge-shaped likelihood is associated with decreased precision. In Figure 8 we take a closer look at these three candidate designs. In the first row, we consider the {n ¼ 10, N ¼ 50} design. The likelihood is able to distinguish between the data-generating truth of {p ¼ 0.1, ¼ 0.75} shown on the left and another point with p & 0.075 shown on the right because the former has a larger point mass at zero and is 'bumpier' in the z > 0 range (e.g. values of 0.11 are highly unlikely). These same differentiating characteristics persist in the n ¼ 20 case in the second row of the figure. In the third row, however, we see that z's likelihood is nearly identical for these two points with a common value of p. This is consistent with the ridge observed in the {n ¼ 50, N ¼ 50} cell of Figure 7 , suggesting that for a true p of 0.1, pools of n ¼ 50 are too large.
We conclude that our model uses the z ¼ 0 pools to obtain information about p that is not confounded by our uncertainty about . We thus benefit statistically from investigating a lowprevalence condition. Given p, our model is able to use the 'bumpiness' of the likelihood in the z > 0 range to obtain information about . We thus benefit from investigating recently infected individuals who can be expected to have a large value of and thus a 'bumpy' likelihood. Importantly, arbitrarily large pool sizes are not advisable, since -as the Central Limit Theorem shows and as we see in Figure 8 -large pool sizes will likely lead to mostly non-zero pools of increasingly homogeneous magnitude. Furthermore -consistent with our comparison of Figures 6 and 7 -as p increases over time, smaller pool sizes are needed to ensure identifiability of p.
A simulation study: comparison with an existing method
Recall that the previous section did not account for measurement error nor sampling variability. In this section, we expand those preliminary findings to the more realistic scenario that includes these complications. We compare the relative strengths of our model-based approach to an existing nonmodel-based estimator, and we provide guidelines for choosing a pool size. 
Simulation setup
For the purposes of this simulation, we focus attention on our motivating example of sentinel resistance surveillance in Botswana. We thus investigate model performance for very low values of p (0.02, 0.04, and 0.06), consistent with the finding of Bennett et al. 5 that the prevalence of transmitted drug resistance had not yet risen above 5% in any of nine completed surveys in Africa. As before, we consider ¼ 0.75 and ¼ 0.90 to reflect the fact the viral populations of treatment-naı¨ve, recently infected individuals with primary resistance have not yet had time to revert to wild type. Furthermore, we restrict our analysis to designs that use N ¼ 50 pools, consistent with the WHO surveillance protocol.
We consider two candidate 'true' data-generating sets of measurement error parameters . The first, (a 0 , a 1 , b, v 0 , v 1 ) ¼ (À7.7, À3.3, 13.7, 0.6, 0.7), estimated from the calibration data depicted in Figure 4 , is characterized by minimal overlap between the observed values of w when the latent z is equal to zero versus when z is positive, implying that measurement error will not confound those pools with k ¼ 0 and those pools with k > 0. In the second scenario, we introduce additional overlap by subtracting two from the data-generating value of a 1 : (a 0 , a 1 , b, v 0 , v 1 ) ¼ (À7.7, À5.3, 13.7, 0.6, 0.7), making the k ¼ 0 pools harder to distinguish from the k > 0 pools. Figure 8 . We investigate the ridge-shaped likelihood observed in the {n ¼ 50, N ¼ 50} cell of Figure 7 . As the pool size n gets large, the likelihood curves become indistinguishable for two points on the ridge in the parameter space.
We simulate data given known 'true' parameter values under a variety of candidate pool sizes for each triplet of p, , and , generating 50 simulated datasets for each parameters-by-pool-size pair of interest. We estimate p separately for each dataset to obtain draws from the sampling distribution of the posterior mean of p. We start the MCMC chains at the parameters' true values. After a burn-in of 1000 iterations, we run each chain for 2500 more iterations.
Alternative estimator
For comparison, for each simulated dataset, we also estimate p using an existing non-model-based approach due to Tu et al. 15, 26 We'll refer to this method as the 'Tu' method for the sake of brevity. Consider a dichotomous test with sensitivity Se and specificity Sp that simply counts the number of pools m with w greater than some cutoff. The Tu method estimates:
where is an estimate of the bias of the unadjusted estimator, detailed in Tu et al. 26 Two appealing features of this method are (a) its ease of implementation and (b) the fact that it does not rely on the truncated normal assumption made by the model described above. The Tu estimator has two potential disadvantages though. First, some information is necessarily lost by dichotomizing the continuous value w. Second, in those cases whenp Tu ¼ 0 orp Tu ¼ 1, we obtain little information about the true prevalence. 26 As we will see below, the latter case is especially misleading in our setting, since the true value of p is small. This method is typically implemented assuming that Se, Sp, and the cutoff are known, fixed properties of the assay. However, we wish to reflect the uncertainty in these values due to our imperfect understanding of the measurement error mechanism, as quantified in our uncertainty about the true value of . We capture this uncertainty by calculating a draw ofp Tu for each posterior draw of . Let t ¼ fa We choose the cutoff for this iteration to be the value c t that gives Se t ¼ Sp t ¼ P(Z 0 > c t ) ¼ P(Z 1 < c t ) (since we have no a priori preference between false negatives and false positives). This cutoff is shown as a red line in Figure 4 . The tth draw ofp Tu is then calculated as a deterministic function of (Se t , Sp t , and c t ). Figure 9 shows that, using our new method, pool sizes of 20 are optimal for a range of currently plausible values of p and , regardless of the severity of measurement error. In contrast to the results presented in Figure 6 , we do not obtain more efficient estimators by increasing n from 20 to 50, especially for larger values of p. We posit that this is because measurement error smooths over the bumpiness in the likelihood that we identified as beneficial in our discussion of Figure 8 .
Implications for choosing a pool size

Comparison of estimators
In Figure 9 , we also compare the performance of the two methods. Most strikingly, these results show that the Tu method is not well-suited to the combination of large pool sizes and large values of p nor to the combination of small pool sizes and more severe measurement error. Either of these combinations may yieldp Tu ¼ 1, which in turns yields very high mean square error (MSE). Given a pool size of 1, we may obtainp Tu ¼ 0. This does not have as severe an impact on MSE, though, because an estimate of zero is not far from the truth in our setting.
We note that, with the exception of those cases contaminated byp Tu ¼ 0 or 1, the Tu method and our model-based method yield roughly comparable results. To assess potential differences in light of Monte Carlo simulation error, we obtain 95% intervals around the ratio of the MSEs of the two estimators for each combination of p, , n, and the measurement error parameters. We use the delta method to approximate the simulation variance of this ratio, accounting for the 'matched' nature of the estimates due to the fact that each simulated dataset was analyzed twice, once by each estimator. With only a few exceptions, the small observed differences between the estimators' performance can be attributed to Monte Carlo variability in our simulation study, implying that the two methods indeed yield comparable results in these cases. This is in contrast to the scenario when no measurement error is present, in which case our model outperforms the Tu estimator for all pool sizes by leveraging the likelihood's bumpiness to differentiate among pools with k ¼ 1 versus 2 versus 3 resistant individuals and thus improve À5.3, À3. 3), we assess estimator performance as a function of pool size (n ¼ 1, 10, 20, 50) for our model and the Tu method. In the left two columns, we show the means and the 2.5th and 97.5th percentiles of theps across simulations. (Note that the y-axis scale differs across rows.) In the right two columns, we compare log MSEs ofp. Pool sizes of 20 appear optimal in most cases. Differences between the estimators are small, except in those scenarios in which the Tu method estimates p to be 1. MSE: mean square error.
inference on p (results not shown). Under the measurement error models considered here though, we lose this advantage -the bumpiness is smoothed over by the large magnitude of v 1 relative to b, resulting in overlapping observed w values corresponding to k ¼ 1 versus 2 versus 3, and implying that not much information is lost by dichotomizing w. Since the difference between a 1 and a 0 is large relative to the v's, the observed values of w values corresponding to k ¼ 0 versus k ¼ 1 do not overlap very much. As a result, measurement error has little impact on inference under the Tu method.
Credible intervals aroundp cover the true value of p 93% of the time under our model-based method, and 85% of the time under the Tu method. The difference between these two values is driven primarily by those cases when the Tu method estimatesp Tu ¼ 1. Note that when the Tu method estimatesp Tu ¼ 0, the credible interval -calculated as suggested by Louis 27 -often covers the truth.
When measurement error is mild, as is the case for the ASPCR assay, and with a p as high as 0.06 and a pool size of 20, the probability of obtainingp Tu ¼ 1 is negligible, so performance of the Tu method will be comparable to our method's. Since it is easy to implement and does not require any assumption about the shape of Y's distribution, the Tu method may thus be preferred. Over time though, p is expected to increase in Africa as it has in the United States. As this occurs, it will be necessary either to decrease pool sizes or to begin using our model-based estimation approach. Since decreased pool sizes would be associated with increased MSE, our method may be preferred. To make things concrete, note that for a true p of 15% and a pool size of 20, there is a 12% chance of obtaining an undesirablep Tu ¼ 1 result, even given the mild measurement error that characterizes the ASPCR assay. By contrast, our method brings prior information about to bear and is thus reliably able to produce informative estimates in this scenario. Furthermore, when surveillance is carried out in a new setting in which prior information about p is not available, our method may be preferred since it is robust to the possibility that p may be large.
As an aside, note that although estimation of p is our primary scientific objective, an important secondary objective is estimation of the prevalence of dominant quasispecies transmitted drug resistance, the proportion of individuals with at least 20% resistant virus:
Although p is the clinically meaningful parameter -since even 'minor variants' may be associated with ART failure 28 -estimation of p d is important for public health program comparisons. In particular, standard HIV genotypic resistance assays are only able to detect resistance mutations that are present above the 20% level in a given sample. 28 For this reason, most published estimates of drug resistance prevalence are in fact estimates of p d . Therefore, surveillance of p d will be important for comparability with existing data. Another advantage of our proposed model over the Tu model is that it yields valid estimates of both p and p d -no additional data need to be collected. Furthermore, MCMC is inherently suited for determining the uncertainty around complex functionals of parameters, such as p d .
Discussion
An inexpensive ASPCR assay enables us to decrease the cost of surveillance by (a) focusing resources on a single important point mutation and (b) pooling multiple samples together to obtain more information from each assay performed. Furthermore, a novel model-based approach allows us to bring virologic prior information to bear, helping to render our parameter of interest identifiable in instances when an existing non-model-based estimator fails. This model-based approach also allows estimation of the prevalence of dominant quasispecies resistance (p d ) at no extra cost.
The methods discussed in this article provide an important statistical component of a proposed HIV drug resistance surveillance program for Botswana. Our end goal is to create a 'black box' statistical software that can be used in the field to obtain precise, low-cost estimates of drug resistance prevalence. In this analysis, we have implemented an adaptive Metropolis algorithm that converges reliably and mixes well without requiring user intervention. 29 As always, though, MCMC takes time and may fail to converge, so importance sampling on a bounded space of plausible parameter values may be considered as an alternative. A potential extension of the methods presented here would generalize them for the multidimensional setting. In particular, for the Botswanan context, we may wish to estimate the joint distribution of the six mutations that are most likely to be circulating given the regimens that have been most commonly used in Botswana (K103N, Y181C, M184V, T215Y, K70R, and K65R). Monitoring their joint distribution in the population over time would thus be useful for informing optimal firstand second-line standardized regimens for Botswana and for learning about HIV drug resistance epidemiology. We note, however, that this would require six separate ASPCR assays to be performed on each pool, cutting into the cost savings that are such an appealing feature of this method.
It may also be of interest to relax the parametric assumption that {YW Y > 0} comes from a truncated normal distribution. Recall, however, that since primary resistance often occurs as the result of infection with a single resistant viral lineage, we wish to restrict the prior space to a set of distributions on (0, 1) that are monotonically increasing -this substantially restricts the range of shapes of distributions that are available. Given this constraint, we chose to use a one-parameter truncated Normal:
I{0 y 1}. A more flexible alternative would be the subset of Beta(, ) distributions that are monotonically increasing. Even within this simple two-parameter family though, there are densities that are inconsistent with the smooth decay of HIV resistance over time and therefore do not seem realistic for our application. If even more flexibility were desired, a hyper prior over distributions could be used in order to allow the data to choose the functional form of P y þ. However, as shown in Figure 8 , we often have trouble identifying even the single parameter of our truncated Normal distribution. We therefore do not expect to be able to identify additional attributes of P y þ. We note however, as we conclude at the end of section 3, that our model uses the z ¼ 0 pools to obtain information about p that is not confounded by our uncertainty about the shape of P y þ. We thus believe that p, our parameter of interest, would be identifiable, even if we were to relax the assumption that Y came from a truncated normal.
These methods may be more broadly applicable, possibly allowing for efficiency gains in prevalence estimation of drug-resistant tuberculosis, malaria, influenza, or hepatitis B, for example. We note, however, that the results presented here depend on the mildness of ASPCR measurement error, the HIV-specific characteristic of infection with a single viral lineage, and on the fact that our surveillance strategy is focused on recently infected individuals. For these reasons, our recommendations about pool size and about the strengths and weaknesses of our method versus the Tu method may not apply in other contexts.
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In each iteration of the second MCMC, we treat one of the draws from the first MCMC as a fixed constant. We update the model's remaining parameters -p, , k, and z -using an adaptive Metropolis algorithm:
(1) Perform a Metropolis update of {p, } by proposing {p*, *} from a bivariate normal distribution centered at the previous values of these parameters, with proposal covariance updated every 100 iterations via the adaptive Metropolis algorithm proposed by Shaby and Wells. 29 A practical difficulty of calculating this acceptance ratio is that the pseudodata likelihood, P(zW , k), is 1/n times a k-fold convolution of truncated normal random variables. For values of k ! 2, this seemingly simple likelihood is not available in closed form. We solve this problem by implementing a novel simulation method that allows us to approximate P(zW , k) in a computationally tractable manner.
. For k ¼ 0, P(zW , k) is simply an indicator, I{z ¼ 0}.
. For k ¼ 1, P(zW , k) is truncated normal: N (1/n, 2 /n 2 ) I{0 y 1/n}. . For each possible value of k in 2, . . . , n, P(zW , k) is not available in closed form. Rather than resorting to asymptotic approximations of the likelihood (as in Graham 18 ), we use simulation to estimate P(zW , k), as depicted in Figure 10 and described here: -For a given value of , simulate k values from the N (1, 2 ) I{0 y 1} distribution. Figure 10 . For k ! 2, P(zW , k) is not available in closed form. We approximate the likelihood via simulation by smoothing over a histogram of draws using a kernel density estimator.
-Sum them and divide by n to obtain a single random draw from P(zW , k).
-Repeat this process to obtain a histogram of 10,000 draws.
-Smooth the histogram using a kernel density estimator, setting the density value outside of [0, k/n] to zero. (2) For each pool in turn, perform a Metropolis-Hastings update of {k, z}:
(a) Propose to decrement or increment k or to keep k constant, with the probabilities of proposing each of these moves updated every 100 iterations during burn-in to obtain theoretically optimal acceptance rates. 30 (b) Propose z* from its full conditional distribution given the proposed value of k. (c) Accept the proposal with the following acceptance probability, using the simulation method described in (1) to calculate P(z W , k)
Pðwjz, ÞPðzj, kÞPðkj pÞ :
